BIOFILCHEM

Biofil Chemicals & Pharmaceuticals Share Price Biofil Chemicals & Pharmaceuticals

₹68.7
+3.3 (5.05%)
17 April, 2024 01:27 BSE: 524396 NSE: BIOFILCHEMISIN: INE829A01014

Start SIP in Biofil Chemicals & Pharmaceuticals

Start SIP

Biofil Chemicals & Pharmaceuticals Performance

Day Range

  • Low 64
  • High 71
₹ 68

52 Week Range

  • Low 41
  • High 79
₹ 68
  • Open Price64
  • Previous Close65
  • Volume118690

Biofil Chemicals & Pharmaceuticals Share Price

  • Over 1 Month +13.46%
  • Over 3 Month +20.53%
  • Over 6 Month +36.04%
  • Over 1 Year +54.21%

Biofil Chemicals & Pharmaceuticals Key Statistics

P/E Ratio 167.1
PEG Ratio 1.6
Market Cap Cr 112
Price to Book Ratio 6.5
EPS 0.3
Dividend 0
Relative Strength Index 56.83
Money Flow Index 65.44
MACD Signal 0.68
Average True Range 4.6
Biofil Chemicals & Pharmaceuticals Financials
IndicatorDec 2023Sep 2023Jun 2023Mar 2023
Oper Rev Qtr Cr 517214
Operating Expenses Qtr Cr 517213
Operating Profit Qtr Cr 0000
Depreciation Qtr Cr 0000
Interest Qtr Cr 0000
Tax Qtr Cr 0000
Net Profit Qtr Cr 0000
IndicatorMar 2023
Total Revenue Annual Cr 30
Operating Expenses Annual Cr 29
Operating Profit Annual in Cr 1
Depreciation Cr 0
Interest Annual Cr 0
Tax Annual Cr 0
Net Profit Annual Cr 1
IndicatorMar 2023
Cash from Operating Activity Annual Cr 0
Cash from Investing Activity Annual Cr 0
Cash from Financing Annual Activity Cr 0
Net Cash Flow Annual Cr 0
IndicatorMar 2023
Total ShareHolders Funds Annual Cr 17
Fixed Assets Annual Cr 9
Total Non Current Assets Annual Cr 9
Total Current Assets Annual Cr 22
Total Assets Annual Cr 31
IndicatorMar 2023
Book Value Per Share Annual Rs 11
ROE Annual % 3
ROCE Annual % 5
Total Debt to Total Equity Annual -
EBDIT Annual Margin % 4
IndicatorDec 2023Sep 2023Jun 2023Mar 2023
Oper Rev Qtr Cr
Operating Expenses Qtr Cr
Operating Profit Qtr Cr
Depreciation Qtr Cr
Interest Qtr Cr
Tax Qtr Cr
Net Profit Qtr Cr
IndicatorMar 2023
Total Revenue Annual Cr
Operating Expenses Annual Cr
Operating Profit Annual in Cr
Depreciation Cr
Interest Annual Cr
Tax Annual Cr
Net Profit Annual Cr
IndicatorMar 2023
Cash from Operating Activity Annual Cr
Cash from Investing Activity Annual Cr
Cash from Financing Annual Activity Cr
Net Cash Flow Annual Cr
IndicatorMar 2023
Total ShareHolders Funds Annual Cr
Fixed Assets Annual Cr
Total Non Current Assets Annual Cr
Total Current Assets Annual Cr
Total Assets Annual Cr
IndicatorMar 2023
Book Value Per Share Annual Rs
ROE Annual %
ROCE Annual %
Total Debt to Total Equity Annual -
EBDIT Annual Margin %

Biofil Chemicals & Pharmaceuticals Technicals

EMA & SMA

Current Price
₹68.7
+3.3 (5.05%)
pointer
  • Bullish Moving Average
  • ___
  • 16
  • Bearish Moving Average
  • ___
  • 0
  • 20 Day
  • ₹65.80
  • 50 Day
  • ₹64.35
  • 100 Day
  • ₹61.31
  • 200 Day
  • ₹57.19
  • 20 Day
  • ₹64.36
  • 50 Day
  • ₹65.91
  • 100 Day
  • ₹61.03
  • 200 Day
  • ₹54.38

Biofil Chemicals & Pharmaceuticals Resistance and Support

PIVOT
₹67.99
Resistance
First Resistance 71.72
Second Resistance 74.73
Third Resistance 78.47
RSI 56.83
MFI 65.44
MACD Single Line 0.68
MACD 1.06
Support
First Resistance 64.97
Second Resistance 61.23
Third Resistance 58.22

Biofil Chemicals & Pharmaceuticals Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 130,687 6,738,222 51.56
Week 74,135 4,008,466 54.07
1 Month 84,788 4,348,777 51.29
6 Month 159,476 7,603,802 47.68

Biofil Chemicals & Pharmaceuticals Result Highlights

Biofil Chemicals & Pharmaceuticals Synopsis

NSE-Medical-Ethical Drugs

Biofil Chemicals belongs to the Industry of Pharmaceuticals. Company’s Total Operating Revenue is Rs. 30.04 Cr. and Equity Capital is Rs. 16.27 Cr. for the Year ended 31/03/2023. Biofil Chemicals & Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 04/01/1985 and has its registered office in the State of Madhya Pradesh, India. Company’s Corporate Identification Number(CIN) is L24233MP1985PLC002709 and registration number is 002709.
Market Cap 112
Sales 38
Shares in Float 0.86
No of funds 4
Yield
Book Value 6.47
U/D Vol ratio 1.4
LTDebt / Equity
Alpha -0.02
Beta 1.76

Biofil Chemicals & Pharmaceuticals

Owner NameMar-24Dec-23Sep-23Jun-23
Promoters 46.82%46.82%46.82%46.82%
Foreign Portfolio Investors 0.03%
Financial Institutions/ Banks 0.04%0.04%0.04%0.04%
Individual Investors 38.04%37.67%37.97%38.1%
Others 15.07%15.47%15.17%15.04%

Biofil Chemicals & Pharmaceuticals Management

Name Designation
Mr. Ramesh Shah Chairman & Managing Director
Mr. Ketan Shah Whole Time Director
Mr. Romil Shah Non Executive Director
Mrs. Gayatri Padiyar Ind. Non-Executive Director
Mr. Ashok Kumar Ramawat Independent Director
Mr. Satish Beohar Independent Director
Mrs. Shaila Jain Independent Director

Biofil Chemicals & Pharmaceuticals Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Biofil Chemicals & Pharmaceuticals Corporate Action

Date Purpose Remarks
2024-02-06 Quarterly Results
2023-11-09 Quarterly Results
2023-08-14 Quarterly Results
2023-05-30 Audited Results
2023-02-14 Quarterly Results

Biofil Chemicals & Pharmaceuticals MF Shareholding

Name Amount(cr)

Biofil Chemicals & Pharmaceuticals FAQs

What is Share Price of Biofil Chemicals & Pharmaceuticals ?

Biofil Chemicals & Pharmaceuticals share price is ₹68 As on 17 April, 2024 | 01:13

What is the Market Cap of Biofil Chemicals & Pharmaceuticals ?

The Market Cap of Biofil Chemicals & Pharmaceuticals is ₹111.8 Cr As on 17 April, 2024 | 01:13

What is the P/E ratio of Biofil Chemicals & Pharmaceuticals ?

The P/E ratio of Biofil Chemicals & Pharmaceuticals is 167.1 As on 17 April, 2024 | 01:13

What is the PB ratio of Biofil Chemicals & Pharmaceuticals ?

The PB ratio of Biofil Chemicals & Pharmaceuticals is 6.5 As on 17 April, 2024 | 01:13

Q2FY23